Veterinary bioburden testing market seen reaching $1.49 billion by 2030

Veterinary bioburden testing services are forecast to grow from $0.99 billion in 2025 to $1.49 billion by 2030 as animal health operators face more pressure to control contamination and infection. The Business Research Company points to zoonotic disease risk, livestock expansion and tighter sterilization standards as key demand drivers.

Why it matters: - Veterinary bioburden testing is becoming a bigger part of animal healthcare, food safety and pharmaceutical quality control. - Rising contamination risks, infection control requirements and regulatory pressure are pushing more testing across veterinary settings. - The market’s projected jump to $1.49 billion by 2030 signals sustained demand for microbial monitoring tools and services.

What happened: - The Business Research Company said the veterinary bioburden testing services market will grow from $0.99 billion in 2025 to $1.07 billion in 2026. - The company forecast the market will reach $1.49 billion by 2030. - The report was released July 8, 2026, from London.

The details: - The market is expected to post 8.3% CAGR from 2025 to 2026. - The report projects 8.5% CAGR from 2026 to 2030. - Veterinary bioburden testing services assess the presence and quantity of microorganisms on animal samples, medical equipment or environments. - The services are used to monitor contamination, verify hygiene and sterilization standards, reduce microbial risks and support infection control. - The report links historical growth to more veterinary hospital-acquired infections, continued use of manual microbial testing and culture techniques, stronger demand for sterilization validation, growth in quality control for veterinary pharmaceutical manufacturing and higher awareness of hygiene standards. - The report says future growth will be driven by AI-powered microbial risk prediction tools, automated and robotics-based laboratory platforms, cloud-based bioburden data management systems, stricter sterilization and infection-control standards, and demand for rapid diagnostics and real-time contamination monitoring. - The report includes a free sample and a full report on the company’s website: sample request and full market report. - The report says North America held the largest market share in 2025. - The Asia-Pacific region is expected to be the fastest-growing market during the forecast period. - The regional analysis also covers South East Asia, Western Europe, Eastern Europe, South America and the Middle East and Africa.

Between the lines: - Zoonotic disease concerns are a major tailwind because pathogen spillover risks rise when human and animal contact increases. - The report cites CDC data showing West Nile virus cases rose from 1,132 in 2022 to 2,628 in 2023. - Expanding livestock production is adding more pressure for systematic bioburden monitoring as herd sizes grow and operations become denser. - UK government reports showed total livestock output reached $23.42 billion (£20.1 billion) in 2024, up 5.6% or $1.28 billion (£1.1 billion) from the prior year. - The market outlook also reflects a broader shift toward automation, data management and faster contamination detection.

What's next: - More lab automation, AI tools and cloud-based systems are likely to become standard in veterinary bioburden testing workflows. - Tighter infection-control rules should keep demand elevated across animal healthcare and veterinary manufacturing. - Asia-Pacific is positioned to capture more growth as the market expands through 2030.

The bottom line: - Veterinary bioburden testing is moving from a niche quality-control service to a core part of infection prevention and compliance in animal health.